SCHEMBL1720374

SCHEMBL1720374

CCCn1c(-c2ccc(NCc3cccc(F)c3)nc2)nc2nc(Cl)[nH]c(=O)c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 1/20 0.43
ORAI1 Q96D31 1/20 0.43
KDM1A O60341 1/20 0.41
CCNT1 O60563 10/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CDK9 P50750 3/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720325 0.77 ADORA3 (0.42) KDM4EALDH1A1ADORA3ADORA2AADORA2B
SCHEMBL2686641 0.77 ADORA2B (0.49) STIM1ORAI1CCNT1ADORA3ADORA2A
SCHEMBL1720586 0.72 EIF4E (0.48) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL1720825 0.72 STIM1 (0.43) STIM1ORAI1CCNT1CDK9KDM4E
SCHEMBL1720377 0.70 CCNT1 (0.41) STIM1ORAI1CCNT1
SCHEMBL2687202 0.68 ADORA2B (0.51) ADORA3ADORA2AADORA2BADORA1
SCHEMBL21667384 0.67 GPR84 (0.45) KDM1AMEN1KMT2AKDM4EALDH1A1
SCHEMBL23860278 0.66 TLR7 (0.34) KDM1ACCNT1CDK9KDM4EALDH1A1
SCHEMBL25173964 0.65 KDM4E (0.42) KDM1ACCNT1CDK9KDM4EALDH1A1
SCHEMBL2686174 0.65 ADORA2B (0.66) ADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed